New developments in radiotherapy of head and neck cancer: Higher precision with less patient discomfort?

Radiotherapy and Oncology

Volumn 85, Issue 1, 2007, Pages 1-6

  Langendijk, Johannes Albertus ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

ACNE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; EDITORIAL; FRACTIONATION; HEAD AND NECK CANCER; HUMAN; IRRADIATION; MORBIDITY; NASOPHARYNX CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL; RASH; RECEPTOR BLOCKING; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY; HEAD AND NECK TUMOR; METHODOLOGY; RADIATION DOSE FRACTIONATION; RADIOTHERAPY;

DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; MORBIDITY; RADIOTHERAPY;

EID: 35248830044     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.07.019     Document Type: Editorial

References (43)

1. Bourhis J., Overgaard J., Audry H., et al. Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-854
2. Paelinck L., Smedt B.D., Reynaert N., et al. Comparison of dose-volume histograms of IMRT treatment plans for ethmoid sinus cancer computed by advanced treatment planning systems including Monte Carlo. Radiother Oncol 81 (2006) 250-256
3. Krayenbuehl J., Davis J.B., and Ciernik I.F. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer. Radiother Oncol 81 (2006) 151-157
4. Steneker M., Lomax A., and Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol 80 (2006) 263-267
5. Saibishkumar E.P., and Jha N. Sparing submandibular gland by IMRT. Radiother Oncol 80 (2006) 106
6. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000) 949-955
7. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578
8. Cummings B, Keane T, Pintilie M, Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer. Radiother Oncol 2007;85: in press.
9. Teo P.M., Leung S.F., Chan A.T., et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 48 (2000) 1311-1322
10. Lee A.W., Tung S.Y., Chan A.T., et al. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66 (2006) 142-151
11. Daoud J., Toumi N., Siala W., Ghorbel A., Drira M.M., and Frikha M. Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma. Radiother Oncol 85 (2007) 17-23
12. Langendijk J.A., Leemans C.R., Buter J., Berkhof J., and Slotman B.J. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 22 (2004) 4604-4612
13. Geets X., Tomsej M., Lee J.A., Duprez T., Coche E., Cosnard G., Lonneux M., and Gregoire V. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 85 (2007) 105-115
14. Senkus-Konefka E., Naczk E., Borowska I., Badzio A., and Jassem J. Changes in lateral dimensions of irradiated volume and their impact on the accuracy of dose delivery during radiotherapy for head and neck cancer. Radiother Oncol 79 (2006) 304-309
15. Barker Jr. J.L., Garden A.S., Ang K.K., et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 59 (2004) 960-970
16. Mohan R., Zhang X., Wang H., et al. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys 61 (2005) 1258-1266
17. Hansen E.K., Bucci M.K., Quivey J.M., Weinberg V., and Xia P. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 64 (2006) 355-362
18. Zhou J., Fei D., and Wu Q. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose?. Int J Radiat Oncol Biol Phys 57 (2003) 673-682
19. Lauve A., Morris M., Schmidt-Ullrich R., et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II - clinical results. Int J Radiat Oncol Biol Phys 60 (2004) 374-387
20. Jensen K., Overgaard M., and Grau C. Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiother Oncol 85 (2007) 90-97
21. Jellema A.P., Slotman B.J., Doornaert P., Leemans C.R., and Langendijk J.A. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva. Radiother Oncol 85 (2007) 83-89
22. Pow E.H., Kwong D.L., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66 (2006) 981-991
23. O'Sullivan B., Warde P., Grice B., et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 51 (2001) 332-343
24. Kagei K., Shirato H., Nishioka T., et al. Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulation. Radiother Oncol 54 (2000) 117-121
25. Jackson S.M., Hay J.H., Flores A.D., et al. Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol 51 (1999) 123-128
26. Gregoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69 (2003) 227-236
27. Levendag P., Braaksma M., Coche E., et al. Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. Int J Radiat Oncol Biol Phys 58 (2004) 113-123
28. Gregoire V., Eisbruch A., Hamoir M., and Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 79 (2006) 15-20
29. Lengele B., Hamoir M., Scalliet P., and Gregoire V. Anatomical bases for the radiological delineation of lymph node areas Part I. Major collecting trunks, head and neck. Radiother Oncol 85 (2007) 146-155
30. Jeanneret-Sozzi W., Moeckli R., Valley J.F., et al. SASRO. The reasons for discrepancies in target volume delineation: a SASRO study on head-and-neck and prostate cancers. Strahlenther Onkol 182 (2006) 450-457
31. de Jong M.A., Koken P.H.W., Jansen E.P.M., Slotman B.J., and Langendijk J.A. Interobserver variability in the delineation of elective nodal areas in the head and neck region. Radiother Oncol 64 (2002) S90
32. Vergeer M.R., Doornaert P., Leemans C.R., Buter J., Slotman B.J., and Langendijk J.A. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol 79 (2006) 39-44
33. Bastholt L., Specht L., Jensen K., et al. Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody againts EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck. Radiother Oncol 85 (2007) 24-28
34. Mydin AR, Armstrong JG. Acneiform rash secondary to cetuximab plus head and neck radiotherapy. Letter to the editor. Radiother Oncol 2007;85:71.
35. Curran D., Giralt J., Harari P.M., et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 25 (2007) 2191-2197
36. Staar S., Rudat V., Stuetzer H., et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1161-1171
37. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
38. Nguyen N.P., Frank C., Moltz C.C., et al. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence. Radiother Oncol 80 (2006) 302-306
39. Jensen K., Bonde Jensen A., and Grau C. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol 78 (2006) 298-305
40. Jensen K., Overgaard M., and Grau C. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation withdose and volume parameters. Radiother Oncol 85 (2007) 74-82
41. Eisbruch A., Schwartz M., Rasch C., Vineberg K., Damen E., Van As C.J., Marsh R., Pameijer F.A., and Balm A.J. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
42. Levendag P., Teguh D., Voet P., et al. Radiation therapy dose in the superior- and middle constrictor muscle and swallowing complaints in cancer of the oropharynx: a dose effect relationship. Radiother Oncol 82 (2007) S13
43. Feng F.Y., Kim H.M., Lyden T.H., et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys (2007) Epub ahead of print